10/29/2018 /
Living with adult-onset epilepsy can challenge a person’s sense of self and trust in their body, resulting in the adoption of various strategies to manage the threat to their identity
10/29/2018 /
CURE is heading to Disneyland for Epilepsy Awareness Day from November 5 – 7, 2018!
10/28/2018 /
Seizure outcome of VNS may be influenced by metabolic connectivity, which can be obtained from preoperative PET imaging.
10/26/2018 /
A new high-tech bracelet, developed by scientists from the Netherlands, detects 85 percent of all severe night-time epilepsy seizures. That is a much better score than any other technology currently available.
10/25/2018 /
Aquestive Therapeutics announced the completion of a study demonstrating that its investigational diazepam buccal film (DBF) provides comparable bioavailability whether administered between seizures or during and shortly after seizures in adult patients with poorly controlled tonic-clonic seizures or focal seizures with impaired awareness.
10/25/2018 /
The perceived stigma of epilepsy was greater than stigma in human immunodeficiency virus/acquired immune deficiency syndrome in Accra.
10/24/2018 /
The FDA has approved abbreviated new drug applications to immediately market a generic version of clobazam (Onfi) (Lundbeck) tablets, CIV, 10 mg and 20 mg, and clobazam oral suspension, CIV, 2.5 mg/mL, for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in patients 2 years of age and older.
10/24/2018 /
Clobazam oral soluble film may improve adherence, reduce likelihood of dosing error, and provide more accurate dosing than currently available formulations of clobazam.
10/24/2018 /
People with epilepsy have elevated self-harm risk, especially in the first year following diagnosis.
